One-off sample handling is often viewed as a Clinical Supply challenge, but similar logistics, tracking, and disposition issues exist across commercial samples, analytical testing materials, and product complaint investigations. A cross-functional methodology was developed to bring together leaders from these traditionally disconnected organizations, align on shared pain points and commitments, and identify common solutions. The approach created a repeatable framework for enterprise problem-solving, reducing redundancy and accelerating implementation through collective ownership and execution.

ICH E6(R3) elevates Quality-by-Design, proactive risk management, and risk-based oversight from regulatory expectations to operational imperatives. This session demonstrates how Clinical Supply leaders can design supply processes that proactively identify and mitigate risks while generating inspection-ready evidence throughout the trial lifecycle. Attendees will gain early understanding of the Clinical Supply document structure within the new Trial Master File (TMF) Standard Model and strategies for aligning documentation with evolving regulatory expectations.

Focused towards smaller organizations, where resourcing may be limited and defined roles and responsibilities murky, this presentation will explore practical approaches to build understanding and partnerships across stakeholders and construct efficient solutions to manage clinical supplies.

Advancing a Phase 3 clinical program within a small biotech requires a fundamentally different operating model than that of large pharmaceutical organizations. This session explores practical and innovative approaches to maximizing limited resources, leveraging strategic partnerships, building agile teams, and prioritizing high-value activities. Attendees will learn how creative thinking, cross-functional collaboration, and disciplined decision-making can enable small biotechs to execute large, complex trials without compromising quality, timelines, or patient experience.